Article

Ruxolitinib Versus Dexamethasone in Hospitalized Adults With COVID-19: Multicenter Matched Cohort Study

2021-06-11

Abstract excerpt

<title>Abstract</title> <p>Background Several anti-cytokine therapies were tested in the randomized trials in hospitalized patients with severe acute respiratory syndrome coronavirus 2 infection (COVID-19). Previously, dexamethasone demonstrated the reduction of mortality in hospitalized patients with a respiratory failure. In this matched control study we compared dexamethasone to a Janus kinase inhibitor, ruxo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3fa509ee-db61-5042-abe6-ec630b5908a8
DOI: 10.21203/rs.3.rs-605939/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ruxolitinib Versus Dexamethasone in Hospitalized Adults With COVID-19: Multicenter Matched Cohort StudyDOI 10.21203/rs.3.rs-605939/v1Read

Ruxolitinib versus Dexamethasone in Hospitalized Adults with Covid-19: multicenter matched-controlled studySemantic proximity Read

Comparative Effectiveness of Dexamethasone in Treatment of Hospitalized COVID-19 Patients during the First Year of the Pandemic: The N3C Data RepositorySemantic proximity Read

Association of Relative Telomere Length with Glucocorticoids Therapy in Critically Ill Patients with COVID-19Semantic proximity Read

The efficacy and safety of monoclonal antibody treatments against COVID-19: A systematic review and meta-analysis of randomized clinical trialsSemantic proximity Read

A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir vs Currently Used Therapy in Severe COVID-19 Adults. “COMVIVIR” Trial.Semantic proximity Read

The efficacy of combination therapies including antiviral drugs, methylprednisolone and daily proning in 20 patients with COVID-19 requiring invasive mechanical ventilation—Case series in a single critical care center in Osaka, JapanSemantic proximity Read

Timely Administration of Tocilizumab Improves Survival of Hospitalized COVID-19 PatientsSemantic proximity Read

On Whether Therapeutic Plasma Exchange is Effective Against Severe/Critical COVID-19 PneumoniaSemantic proximity Read

Outcomes of Patients with COVID-19 in the Setting of Chronic Opioid Use DisorderSemantic proximity Read

‘Which severe COVID-19 patients could benefit from High dose dexamethasone? A Bayesian reanalysis of a randomized clinical trialSemantic proximity Read

Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic dataSemantic proximity Read

Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection.Semantic proximity Read